AirBnB ABNB stock analysis 25SEP23

Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials

Biomea’s BMF-219 is an investigational irreversible covalent inhibitor of menin. Image credit: eamesBot / Shutterstock. Biomea Fusion’s stock is on the up after the company

September 27, 2024

Canopy Growth Q1 Cannabis Revenue Jumps 12% Sequentially

Canopy Growth Reports First Quarter Fiscal Year 2024 Financial Results Net revenue in Q1 FY2024 increased 3% year-over-year to $109 million. Adjusting for divestiture of

August 10, 2023

Enzyme released by immune cells may play role in depression

Mount Sinai researchers have shown for the first time that immune cells called monocytes, derived in the bone marrow and released into the bloodstream, can

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.